A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections

• Main Authors: Purwati, -, Budiono, -, Brian Eka Rachman, -, Yulistiani, -, Andang Miatmoko, -, Nasronudin, -, Soroy Lardo, -, Yongki Iswandi Purnama, -, Mafidhatul Laely, -, Ike Rochmad, -, Taufik Ismail, -, Sri Wulandari, -, Dwi Setyawan, -, Alfian Nur Rosyid, -, Herley Windo Setiawan, -, Prastuti Asta Wulaningrum, -, Tri Pudy Asmarawati, -, Erika Marfiani, -, Shinta Karina Yuniati, -, Muhammad Rabiul Fuadi, -, Pepy Dwi Endraswari, -, Purwaningsih, -, Eryk Hendrianto, -, Deya Karsari, -, Aristika Dinaryanti, -, Nora Ertanti, -, Igo Syaiful Ihsan, -, Disca Sandyakala Purnama, -, Yuni Indrayani, -
• 格式: Article PeerReviewed
• 語言: English; English; English
• 出版: Hindawi 2021
• 主題: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• 在線閱讀: https://repository.unair.ac.id/123735/2/C-21%20Artikel.pdf; https://repository.unair.ac.id/123735/1/C-21%20Kualitas%20Karil.pdf; https://repository.unair.ac.id/123735/3/C-21%20Similarity.pdf; https://repository.unair.ac.id/123735/; https://www.hindawi.com/journals/bri/2021/6685921/; https://doi.org/10.1155/2021/6685921

Background. At the present time, COVID-19 vaccines are at the testing stage, and an effective treatment for COVID-19 incorporating appropriate safety measures remains the most significant obstacle to be overcome. A strategic countermeasure is, therefore, urgently required. Aim. This study aims to ev...